It was suggested that an appropriate intake of tyrosine and phenylalanine ranged from 30 to 40mg/kg/day for dietary control of tyrosinemia in infancy. It was also pointed out that over-restriction of tyrosine and phenylalanine might cause a failure to gain weight and an increased susceptibility to infections.
Tyrosinemia is a hereditary disorder characterized by cirrhosis of the liver, renal tubular defects and hypophosphatemic rickets.1-3 The main biochemical features of this disorder are an elevated tyrosine level in serum and increased excretion of p-hydroxyphenylpyruvic acid (pHPPA), p-hydroxyphenyllactic acid (pHPLA) and p-hydroxyphenylacetic acid (pHPAA). It has been demonstrated that pHPPA oxidase is absent in the liver of the patients with tyrosinemia.1,2,4 Treatment with a diet low in tyrosine and phenylalanine has been recommended for this particular disorder.5 This paper will describe clinical observations of an infant with tyrosinemia who has been put on a diet low in tyrosine and phenylalanine.
CASE REPORT H.S., a boy, was born weighing 2.6 kg with pelvic presentation after a full term pregnancy and spontaneous delivery. The parents were healthy and not consanguineous.
There was no sibling. The patient was fed on mother's milk by one month of age and then the diet was changed to the cow's milk formula.
The patient was admitted to our Clinic because of developmental retardation, abdominal distension and jaundice at the age of 4 months.
On admission, physical examination showed a poorly nourished boy whose size corresponded to that of a 2-month-old infant. He could not hold up his head yet. The skin and conjunctiva were icteric. The lungs and heart were clear to ausculta X-ray films of the distal end of the radius showed typical changes of rickets.
Two dimensional thin-layer chromatography revealed generalized amino aciduria with a prominent increase in tyrosine.
Amino acid levels in serum were determined by an automatic amino acid TALE 1. Amino acid levels in serum from our patient with tyrosinemia (pmoles/l) The patient showed a prolonged elevation of serum tyrosine following the test dose (cf. Fig. 1 ). Urinary tyrosyl compounds were analyzed by thin-layer chromatography as described by Scriver et al. 7 It was found that the patient excreted 200 to 300mg of tyrosyl compounds per day, consisting of 30% pHPLA, 7% HPPA, 30%pHPAA and 33% tyrosine.
Basing upon the results mentioned above, the diagnosis of tyrosinemia was established.10
TREATMENT At the age of 5 months, the treatment with a diet low in tyrosine and phenyl alanine was started. The composition of this specific milk was shown in Table 2 .
This milk contained well-balanced nutrients and sufficient amounts of vitamins and of minerals, except for the low contents of tyrosine and phenvlalanine.
Clinical course of the patient during the treatment was summarized in Fig . 2 .
In the early period of the dietary regimen, the daily intake of tyrosine and phenyl alanine was restricted to 13mg and 18mg per kg of bodyweight, respectively; these values were coresponding to one-fourteenth and one-tenth of the amounts given in the pretreatment period. On this diet, daily intake of protein was equivalent to 3.5 g/kg and the daily intake of calories was 180Cal/kg. With the dietary regimen, serum tyrosine level began to drop to 0.36mg/100ml in the third week and Millon's reaction became weak. Hepatosplenomegaly tended to reduce in grade with fading of jaundice. There was, however, little gain in weight. The body weight began to decrease and in the 6th week the patient was affected by the upper respiratory infection with complication of pneumonia. This was thought to be due to 'over-restriction' of tyrosine and phenylalanine resulting in decline in the syn thesis of protein. Therefore, the diet was modified to provide 30mg/kg of tyrosine and 35mg/kg of phenylalanine in daily intake in the seventh week of the treatment. Under this dietary regimen, the patient began to show a steady gain in weight.
In three months of the treatment, a noticeable improvement of clinical symptoms was observed (Table 3) ; hepatosplenomegaly disappeared, liver function was improved, anemia was restored, proteinuria, glucosuria and generalized aminoaciduria disappeared, and rachitic findings of the bone end also showed gradual healing.
Since 9 months of age, solid food containing chiefly carbohydrates and fat was supplemented in addition to the specific milk ; daily intake of tyrosine and phenyl alanine was raised to 45mg/kg and 50mg/kg, respectively, and further raised to 68 mg/kg and 71mg/kg. At present the child is one year and three months old and apparently healthy. His physical size is within normal limits, although mental development seems to be somewhat retarded. He can stand up without support.
Liver biopsy was performed twice at the age of 4 months (before the treatment) and at the age of 11 months (6 months after the beginning of the treatment) for histological examinations (cf. Fig. 3 ). The first specimen showed the findings of 
COMMENT
Since Halvorsen and Gjessing5 made the first trial of low-tyrosine and low phenylalanine diet for a patient with tyrosinemia, several reports on dietary treat ment of this particular disorder have appeared in the literature.'-10 Most authors have agreed to the view that the dietary restriction of tyrosine and phenylalanine has a beneficial effect on this particular disorder.
In our experience with the present patient, it must be emphasized that 'over restriction' of tyrosine and phenylalanine results in failure to thrive and in enhanced susceptibility to infections.
Kogut et al.9 also described that failure to gain in weight, development of alopecia and infectious rash took place when a patient with tyrosinemia had been placed on a diet providing 5mg/kg/day of tyrosine and 43mg/kg/day of phenylalanine. In phenylketonuria, it is often pointed out that 'over-treatment' causes severe complications such as failure to thrive, anemia or seizures probably on account of phenylalanine deficiency.11
Appropriate amounts of tyrosine and phenylalanine in dietary treatment of tyrosinemia in infancy is obscure because of scanty reports. The experience in the present patient suggests that a daily intake of 30 to 40mg/kg of tyrosine and phenylalanine, respectively, is recommended for the dietary control of tyrosinemia in infancy. 
